From the article: > An EMA safety committee is looking at adverse events raised by the Icelandic Memdicines Agency, including two cases of suicidal thoughts po

From the article: > An EMA safety committee is looking at adverse events raised by the Icelandic Memdicines Agency, including two cases of suicidal thoughts potentially linked to Ozempic and Saxenda, the regulator said. > One additional patient on Saxenda reported thoughts of self-injury, the agency said. Given that Ozempic (and I imagine Saxenda) have been positive for many people when it comes to weight management, I hope that either 1) these are individual cases that can be handled safely, or 2) a safer alternative can be found.